We’ve all been taught not to prescribe addictive drugs to patients who will abuse them, but in the real world it is not always easy to tell who those patients are or to manage the resulting problems.
Read More
What are some ways clinicians can minimize the risks to patients and their own liability in psychiatric practice? Dr. Paul Appelbaum explores risk management in clinical practice in this month’s Q&A.
Read More
Do patients with major depressive disorder (MDD) respond better when psychiatrists offer the type of treatment—medication or psychotherapy—that the patient prefers?
Read More
No one seems to be without a cell phone these days, so it only makes sense that we should start using these devices to carry out tasks that we used to do in a more “old-fashioned” way.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
